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Abstract: Exposure to ultrafine particles (UFPs) leads to adverse effects on health caused by an
unbalanced ratio between UFPs deposition and clearance efficacy. Since air pollution toxicity is first
direct to cardiorespiratory system, we compared the acute and sub-acute effects of diesel exhaust
particles (DEP) and biomass burning-derived particles (BB) on bronchoalveolar Lavage Fluid (BALf),
lung and heart parenchyma. Markers of cytotoxicity, oxidative stress and inflammation were analysed
in male BALB/c mice submitted to single and repeated intra-tracheal instillations of 50 µg UFPs.
This in-vivo study showed the activation of inflammatory response (COX-2 and MPO) after exposure
to UFPs, both in respiratory and cardiovascular systems. Exposure to DEP results also in pro- and
anti-oxidant (HO-1, iNOS, Cyp1b1, Hsp70) protein levels increase, although, stress persist only in
cardiac tissue under repeated instillations. Statistical correlations suggest that stress marker variation
was probably due to soluble components and/or mediators translocation of from first deposition
site. This mechanism, appears more important after repeated instillations, since inflammation and
oxidative stress endure only in heart. In summary, chemical composition of UFPs influenced the
activation of different responses mediated by their components or pro-inflammatory and pro-oxidative
molecules, indicating DEP as the most damaging pollutant in the comparison.
Keywords: air pollution; ultrafine particles; inflammation; oxidative stress; diesel exhaust particles;
biomass burning
1. Introduction
Air pollution is a global public health emergency that affects people of all ages in every part of
the world. Nowadays, addressing ambient air pollution is the government priority, and the World
Health Organization [1] issues air quality guidelines to defend the population in general and the most
vulnerable in particular.
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Numerous epidemiological studies have showed the effects of air pollution on the respiratory and
cardiovascular systems. Short-term exposure to air pollution at higher levels reduces life expectancy by
aggravating pre-existing respiratory and cardiovascular diseases [2]. Cardiovascular effects induced
by particulate matter (PM) are linked to particle deposition in the lungs, to their translocation through
the air-blood barrier to extra-pulmonary sites and the resulting systemic inflammation [3–6]. Particles’
deposition rates are strictly linked to the particle size: smaller particles have the highest deposition
efficiency. Furthermore, ultrafine particles (UFPs, with an aerodynamic diameter less than 100 nm)
are predominant when considering particle size number distribution while they contribute modestly
when considering mass size distributions [7]. UFPs are probably the main mediators of PM toxicity
due to the greater penetration efficacy into the respiratory system and to the higher translocation rates
from the airways into the blood circulation [8,9]. Furthermore, UFPs are able to inhibit phagocytosis
by enhancing their interaction with the alveolar epithelium [7]. Particles with a high surface area to
mass ratio are able to adsorb potentially toxic organic chemicals or metals, increasing their capability
to be a source of ROS [10,11]. Additionally, several studies evidenced that air pollutant composition is
responsible for different toxic effects [12]: UFPs, due to their high organic chemicals content provide
proportionally more redox cycling chemicals than larger particles [13]. Therefore, UFPs can show worse
and different toxicity profiles in comparison to those of larger particles with the same composition,
since their specific interaction with lung cells and their capability to translocate across the alveolar
epithelial barrier [14]. Nonetheless, it cannot be excluded that systemic toxicity may be mediated also
by PM or UFPs associated water-soluble components and/or biochemical mediators released in the
lung and then translocated in blood circulation.
In Lombardy (North of Italy) diesel combustion and solid biomass burning are responsible for the
15% and the 50% of the primary fine particles production, respectively [15]. Combustion processes,
if not complete, lead to the formation of particles of 15–30 nm in diameter, contributing largely to
primary UFP emissions [16,17]. Diesel exhaust is a complex mixture of solid, condensed (or liquid), and
gaseous corpuscular fractions [18]. The solid fraction is represented by diesel exhaust particles (DEP),
with a bio-persistent core of about 10–30 nm in diameter [19]. These primary particles, composed of
elemental carbon, can then agglomerate into larger soot aggregates with mean diameters of 60–100
nm [18]. The DEP surface can adsorb more than 300 chemical compounds, which include polycyclic
aromatic hydrocarbons (PAHs), aliphatic hydrocarbons, quinones, transition metals and others [20].
Moreover, biomass burning (BB)-derived particles are obtained due to inefficient combustion that
generates a multitude of partially oxidized organic chemicals, many of which have been associated
with adverse health impacts [21].
In-vivo and in-vitro toxicological studies have evidenced diverse cardiovascular effects due to
the particles’ origins and composition [22–26], which differently modulate inflammatory mediators
and oxidative stress events [27]. Traffic-derived particles seemed to retain a higher inflammatory
potential comparing to biomass particles in specific cellular models [28,29] but little is known about
their systemic effects. Here we present a comparative in-vivo study aimed to elucidate the putative
differences between the responses elicited by UFPs derived from diverse anthropogenic sources (DEP
and BB). Intratracheal instillation of particulate matter in BALB/c mice is a useful and validated
in-vivo model to study pollutants induced toxicity [30–32]. Therefore, we analyzed in this model
how a short-term exposure or repeated exposures to DEP or BB could differently affect a panel of
pro-inflammatory, cytotoxic, and oxidative stress markers in bronchoalveolar lavage fluid (BALf),
lung and heart parenchyma, since they may not share the same biological mechanisms [33]. Thus,
to clarify the specific cardiopulmonary damaging effects of short term and long-term exposure to
different pollutants, could provide useful information for air quality standards guidelines and to
clinical prevention for cardiovascular disease.
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2. Results and Discussion
2.1. DEP Induced Higher Inflammatory Response than BB in BALf of Treated Mice
Cell-mediated immunity represents the first response triggered that indicates particles’ damage
in pulmonary tissue. Under physiological conditions, healthy mice show a prevalence of alveolar
macrophages (AMs) as resident immune cells in the lungs [34]. In response to exogenous agent
inhalation, the recruitment of polymorphonuclear cells (PMNs) cooperate with AMs to phagocyte and
eliminate particles [35]. Histological evaluation of lung parenchyma provided us qualitative information
about the inflammatory status and potential pathological changes in the target organ. Phagocytic cells
loaded with particles were observed in the bronchiolar epithelium either after acute and sub-acute
exposure (Figure 1). In sham mice, lung parenchyma appeared normal (Figure 1A,B,G,H), while lung
of UFPs-treated mice showed internalization of particles by phagocytic cells. Contrarily to BB-treated
mice, where occasional particle internalization occurred (Figure 1C,D,I,J), DEP exposure showed
several phagocytic cells containing particles in alveolar spaces and interstitium (Figure 1E,F,K,L).
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Figure 1. Lung histological analysis. Representative histological images of lung after single (A–F) or
repeated (G–L) intratracheal instillation with 50 µg of BB (C,D,I,J) or DEP (E,F,K,L) in 100 µL 0.9% NaCl.
Arrows indicate phagocytic cells containing particles in alveolar space and interstitium. (A,C,E; G,I,K)
Bars = 50 µm; (B,D,F; H,J,K) Bars = 20 µm.
In parallel, in the BALf of mice subjected to acute UFPs treatment, we observed a significant
increase of PMN percentage in parallel to a decrease of AM percentage. Although the trend of cell
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count was similar after both UFPs treatment, DEP-exposure led to a significant increase of PMNs (71%
of BALf total cells) and a significant decrease of AMs (29% of BALf total cells) (Table 1).
Table 1. Cell count and biochemical BALf analysis. Table summarizes results of cell count and
biochemical analysis in BALf of sham, BB- and DEP-treated mice after 3 h from the single intratracheal
instillation (day 0) and after 24 h from the last intratracheal instillation (day 6). All the data are
expressed as mean ± standard error. Concentrations under the detection limit are reported as <LOD.
Statistical differences were tested by One-way ANOVA followed by Bonferroni post-hoc comparison;
* p < 0.05 vs. sham, § p < 0.05 vs. BB.
Single Instillation Repeated Instillation
sham BB DEP sham BB DEP
mean st.er. mean st.er. mean st.er. mean st.er. mean st.er. mean st.er.
Total Cells (E+06/mL BALf) 2 0.4 1.3 0.4 3 *§ 0.7 1.46 0.72 0.94 0.16 0.79 0.28
AMs% 85.7 9.8 59.5 12.2 29 *§ 10 65.03 11.5 47.14 4.5 43.27 6.5
PMNs % 14 9.9 40 12.4 71 *§ 10 34.56 0.39 0.43 0.25 0.35 0.16
Ls % 0.3 0.3 0.5 0.4 0.1 0.1 0.39 0.24 0.23 0.04 0.22 0.02
Total Protein (mg/mL) 0.2 0.1 0.2 0.1 0.4*§ 0.1 0.21 0.02 108.91 7.7 88.32 19.7
LDH (mU/mL) 75.2 7.1 119.3 * 8.8 124.3 * 9.0 76.1 14.7 0.11 0.04 0.09 0.01
ALP (IU/L) 0.2 0.1 0.1 0.1 0.2 0.1 0.12 0.01 2.03 0.11 1.83 0.2
TAC (Trolox (nmol/mL)/Tot
Pt (mg/mL)) 1.7 0.1 1.9 0.2 1.5 § 0.1 2.44 0.29 6.67 1.02 5.01 0.55
ET-1 (pg/mL) 3.8 0.6 3.6 0.3 8.5 *§ 1.1 6.91 1.05
Hsp70 (ng/mL) 0.6 0.1 0.7 0.1 0.7 0.1 0.46 0.05 0.43 0.02 0.43 0.02
TNFα (pg/mL) 55.5 31.6 90.8 39.2 238.2 97 <LOD <LOD <LOD
IL-6 (pg/mL) 17.1 13.3 41.1. 20.3 70.9 11.4 <LOD <LOD <LOD
MMP-9 (pg/mL) 918.55 709.5 3932.9 2053.1 9100.4 3772.6 606.4 230.8 433.8 67.1 413.4 102.7
The high levels of lactate dehydrogenase (LDH), increasing about 1.5-fold after UFP treatment,
led us to hypothesize the occurrence of necrotic damage (Table 1). The unvaried value of alkaline
phosphatase (ALP) activity, a specific marker of Type I pneumocytes damage [36], suggests necrosis of
AMs overloaded with particles in response to a failure of the macrophage clearance mechanism [37].
Indeed, LDH enzyme in BALf inversely correlated to AM percentage, pointing out that necrotic
damage was probably directly affecting immune cells resident in the lung. The influx of PMNs (i.e.,
neutrophils 99%) is strongly associated with an acute inflammatory reaction [38]. Neutrophils contain
four different classes of granules: azurophilic, specific, gelatinase granules and secretory vesicles.
Neutrophils degranulation, occurring after their stimulation, induces a release of inflammatory markers
into the extracellular space: specifically myeloperoxidase (MPO) is released from azurophilic granules
while matrix metalloproteinase-9 (MMP9) from gelatinase granules [39]. Both these proteins when
released are involved in lung injury [39,40], modulating the release of other biochemical mediators and
extracellular matrix remodelling [41]. Accordingly, short-term exposure to UFPs leads to significant
increase in MPO and an increasing trend in MMP9, indicating activation of infiltrated neutrophils in
both the treatments. Interestingly, DEP promoted a stronger increment of MPO (2-fold) (Figure 2)
compared to sham (3-fold compared to BB) and a 10-fold increase in MMP9 amount (Table 1), in line
with the major recruitment of neutrophils observed. Moreover, BALf total protein concentration
doubled after DEP treatment, suggesting an increased permeability of the air-blood barrier (Table 1).
Indeed, the acute inflammatory event is associated with vascular leakage, essential to allow leucocyte
migration to inflammation site [42,43].
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Figure 2. MPO protein levels in BALf after single and repeated instillations of BB and DEP.
Representative immunoblotting images of MPO analysis in mice after single and repeated instillations
with 50 µg of BB or DEP/100 µL 0.9% NaCl. MPO data are indicated as fold-change with respect to
sham. Proteins have been normalized for corresponding total proteins revealed by Ponceau staining
in each lane and the data are expressed as mean ± standard error (n = 6). Statistical differences were
tested accordingly by One-way ANOVA followed by Bonferroni post-hoc comparison. * p < 0.05 vs.
sham mice.
The higher toxic potential of DEP is also revealed by the increased ET-1 concentration in the
BALf, probably secreted from lung endothelial cells, as well as by AMs. ET-1 could promote acute
lung injury, inducing cytokine production and activating neutrophils to release oxygen radicals [44].
Actually, levels of TNF-α and IL-6 pro-inflammatory cytokines were 4-fold augmented in BALf of
DEP-treated mice. Although cytokine incre ent is not significant, TNF-α and IL-6 had a positive
correlation between themselves as well as with the influx of PMN percentage in the BALf and MMP9
amount (Figure 3).
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Figure 3. Correlation analysis in BALf. Dispersion plot showing the co-distribution of BALf parameters
in acute treatment. Linear regression correlations are displayed as black lines.
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Indeed, IL-6 could dictate the profile of leukocyte recruitment during the inflammatory
response [45] while TNF-αmay stimulate specific degranulation and MMP9 release [39]. Similarly, MPO
positive correlation with PMNs percentage and ET-1 could depend by active neutrophils stimulated
to release MPO. Our evidences pointed out UFP ability to activate in the lung a local inflammatory
response during the acute insult, and showed higher effects induced by UFP derived from diesel
combustion compared to the ones resulting from biomass burning.
With the sub-acute treatment, we did not observe a significant change of BALf parameters
among the three groups, suggesting some kind of adaptation to the inflammatory status caused
by desensitisation after repeated exposures. After DEP-treatment, MPO protein level resulted the
only parameter significantly higher than sham, although it appeared lower when compared with the
acute exposure (Figure 2). We supposed that this event was due to a lower recruitment of PMNs
after repeated instillations with respect to the single one, according to a global re-establishment of
others BALf parameters. Finally, high MPO protein levels might be associated to the persistence of
particle-loaded phagocytic cells in lung parenchyma after DEP exposure. MPO, hence, results a useful
biomarker for evaluating the pulmonary toxicity of inhaled chemicals since high concentrations of
protein keep on for a long time after instillation [46].
2.2. Both UFPs Induced Inflammatory Response in Lung and Heart Parenchyma of Treated Mice
The heart is the first organ directly reached by the bloodstream coming from the lungs, through the
pulmonary circulation. Thus, although histologic analyses did not show infiltration of phagocytic cells
overloaded with BB and DEP particles in the hearts of treated-mice (data not shown), UFP components
or pro-inflammatory molecules produced in lung might immediately translocate and reach the
cardiac tissue.
Airway diseases have been already associated with cyclooxygenase 2 (COX-2) regulation at both
gene and protein levels in-vitro and in-vivo following DEP treatment [47–49], but little is known about
BB. In order to understand if the acute inflammation observed was associated to this key modulator
of airway inflammation [50], COX-2 protein levels were evaluated in lung and heart parenchyma.
In acute treatment, instillation of both BB and DEP caused an increase of COX-2 protein levels with
a stronger increase in the heart (about 2-fold) than in lung (about 1.7-fold) with respect to sham
(Figure 4A). Interestingly, in sub-acute treatment, COX-2 levels were maintained higher 24 h after the
last intratracheal BB or DEP instillation (Figure 4A). Considering that in the cardiovascular system,
COX-2 activity is associated with the control of leukocyte-endothelial cell adhesion and platelet
aggregation [51] its activation may potentially be involved in endothelial dysfunction and, in turn, in
atherosclerosis progression [52]. Accordingly, MPO levels significant increased respect to sham after
both acute and sub-acute DEP-treatment (about 1.7-fold and 1.5-fold respectively) (Figure 4B), also in
the heart parenchyma, while BB determined not significant increases. This data results very remarkable
considering that the MPO locally released by immune cells could transcytoses to the sub-endothelial
matrix from vascular endothelium [53].
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Figure 4. Inflammatory markers protein levels in lung and heart parenchyma. Representative
immunoblotting images of COX2 analysis in mice lung and heart (A) and of MPO in heart parenchyma
(B) after single and repeated instillations with 50 µg of BB or DEP/100 µL 0.9% NaCl. Histograms
display COX2 and MPO as fold-change with respect to sham. Proteins have been normalized for
corresponding total proteins revealed by Ponceau staining in each lane and the data are expressed as
mean ± standard error (n = 6). Statistical differences were tested accordingly by One-way ANOVA
followed by Bonferroni post-hoc comparison. * p < 0.05 vs. sham mice; § p < 0.05 vs. BB.
Thus, elevated MPO levels after DEP treatment might result in its higher passage in heart
parenchyma with an increasing cardiovascular risk [54] although the histochemical data here reported
did not completely supported this hypothesis. In UFP-treated mice, lung injury activated MMP9
protein through neutrophil degranulation, as an effect of local inflammation [39]. Thus, considering
the observed MMP9 increment in BALf, a possible metalloproteinase activation following BB or DEP
intratracheal administration was explored in living mice, using the FMT 1500 fluorescence imaging
system and the MMPSenseTM 750 FAST. This probe is a matrix metalloproteinase (MMP) agent that
is optically silent upon injection and produces a fluorescent signal after cleavage by inflammation
related MMPs (MMP-2, 3, 7, 9, 12, and 13). Since the recommended optimal imaging time point is
6–24 h post-injection of the probe, the MMP activity evaluation after 3 h from single instillation was
not possible. For this reason, in order to compare the effects of the single and the repeated exposures,
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in-vivo imaging was performed 24 h post-injection from the first (day 1) and the last (day 6) instillation
in the sub-acute treatment.
In the thoracic region, 24 h after the first instillation, the MMPSenseTM 750 FAST showed a
6-fold increase for BB (Figure 5B) and a 1.5-fold increase for DEP (Figure 5C), comparing to sham
(Figure 5A). Similarly, 24 h after the last instillation, the signals for BB were found to be higher (1.6-fold)
(Figure 5E) with respect to sham as well as to DEP (Figure 5F) that returned comparable to control
levels (Figure 5D). Interestingly, initial data have indicated that BB treatment was more effective than
DEP in MMPs activation (Figure 5G) although the biochemical and histological analysis here reported
showed a higher impact of DEP.It is possible to speculate that since BB is enriched in Mn, an inductor
of MMP proteins [55], specific metal and trace elements concentration may have a primary role in the
activation of different pathways along the time. Indeed BALf analyses were performed after 3 h from
the single instillation, while FMT, for techincal esigence, after 24 h.
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Figure 5. FMT of mouse thoracic region after the first (A–C) and the last (D–F) instillation of BB and
DEP. Representative FMT images of sham (A), BB- (B) and DEP- (C) treated mice brain obtained 24 h
after the first intratracheal instillation with 50 µg of BB or DEP/100 µL 0.9% NaCl. Representative FMT
images of sham (D), BB- (E) and DEP- (F) treated mice brain obtained 24 h after the last intratracheal
instillation with 50 µg of BB or DEP/100 µL 0.9% NaCl. Each figure represents the status evidenced
examining two ice for every treatment, and histograms (G) are representative of pmol of MMPsense
750 FAST probe. Data are expressed as mean ± stand rd error.
Moreover, MMP9 protein level increment in BALf after DEP (Table 1) was probably due to a
release from neutrophils, while FMT give us a picture of the all MMPs activation in the whole thoracic
area, evaluating not only BALf but all the organs involved in the cardiovascualar injury.
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2.3. DEP Induced Higher Oxidative Stress Response than BB in Lung and Heart Parenchyma of Treated Mice
Notably, DEP exposure had the major stress outcome, while no significant changes were observed
after BB exposure. Longhin et al. [56] using the same UFP batches in in-vitro models, reported that
DEP exposure induced a stronger modulation of gene transcription as compared to BB in term of
both differentially expressed genes, temporal patterns and pathway activation. The authors showed
that DEP was enriched in polycyclic aromatic hydrocarbons (PAHs), such as pyrene, phenanthrene,
benzo[a]anthracene and dibenzo[a,h]anthracene which may induce oxidative stress.
Indeed, PAHs are inducers and substrates of cytochrome P450 enzymes like Cyp1b1 [57], an enzyme
implicated in their detoxification. Transformation of PAHs by cytochrome P450 could lead to reactive
oxygenated intermediates able to interact with and oxidize cellular macromolecules [58,59]. Cyp1b1
increased significantly immediately after the DEP single instillation in lung and heart parenchyma,
whereas during sub-acute treatment significant levels of this enzyme occurred only in cardiac tissue
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In parallel to the activation of pro-oxidant protei s, in DEP-treated mice we observed the
up-regulation of antioxidant and protective enzymes, such as heme oxygenase 1 (HO-1) and heat shock
protein 70 (Hsp70) (Figure 6C,D). HO-1 activity plays an important role in the antioxidant response
since it generates anti-inflammatory and anti-oxidant molecules in the rate-limiting step of heme
degradation [61]. After the acute exposure to DEP, HO-1 significantly increased (3-fold) with respect to
sham (Figure 6C), suggesting an immediate reaction of lung tissue to counteract the oxidative stimulus,
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as already demonstrated in response to particulate matter [6,30,62]. The antioxidant enzyme activation
persisted also after the last instillation of the sub-acute treatment with DEP although dampened with
respect to a single event. Interestingly, while HO-1 increased in lung parenchyma and Hsp70 levels did
not, the opposite was observed in the cardiac tissue. Hsp70 acts as a chaperone in maintaining normal
cell function after different insults, including oxidative stress and pro-inflammatory cytokines [63].
In cardiac tissue protein levels increased immediately after acute exposure (Figure 6D) possibly in
relation to the high content of PAHs, Zn and V, adsorbed onto DEP. These compounds were in fact
described as inducers of Hsp70 expression [64,65]. As observed for Cyp1b1, Hsp70 levels were still
higher after sub-acute exposure to DEP. We speculate that, since PAHs are able to form PAHs-albumin
adducts, PM-desorbed PAHs in the lung and bounded to albumin as a carrier could be able to pass
the alveolar epithelium and endothelium and eventually reach other target tissues [66,67], suggesting
a delayed translocation of PAHs rather than of UFPs. Interestingly recently it has been shown in
cells exposed to real world UFPs the high correlation of HO-1, Cyp and inflammatory proteins to
specific chemical compounds associated to vehicular traffic and biomass burning emissions [68] again
suggesting that the release of such compounds from soot particles may be relevant to understand
particles-associated health effects.
Moreover, MPO high levels in heart of DEP-treated mice could be another potential source of
oxidative stress, since ROS produced by its enzymatic activity may affect the PAHs transformation to
highly reactive intermediates [32,69].
The decrease of pro- and anti-oxidant protein levels in lung under sub-acute DEP treatment,
compared to acute event, suggests that the antioxidant systems were active only until the pro-oxidant
stimuli were high in the first deposition site. Then, the antioxidant machinery tended to burned out,
although it might rest sensitive to successive acute events. On the other hand, frequent exposure to
DEP might sustain prolonged oxidant stress environment in close or distant organs from pollution
instillation locus.
2.4. The Interdependence between Oxidative Stress and Inflammation Following DEP-Exposure
Oxidative stress and inflammation are pathophysiological events strictly connected, cause and
consequence of each other in several diseases [70,71], including those induced by air pollution exposure.
Here we showed the co-presence of both processes, and their interplay among the organs evaluated.
At intra-organ level the inflammatory marker COX-2 increase was associated with both HO-1 and
iNOS protein levels after the single instillation in the lung (Figure 7A), as well as the inflammatory
marker correlated with Hsp70 protein in heart parenchyma (Figure 7B).
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Moreover, during the inflammatory processes activated neutrophils and macrophages produces
large amounts of ROS that might diffuse out of the phagocytic cells and in uce localized oxidative
stress and tissue injury [72]. Indeed, inflammatory and oxidative stress markers expressed in different
fluids or tissues of DEP-treate mice were statistically correlated (Table S1). A condition of systemic
inflammation was demonstrated by the correlations among lung COX-2 and heart MPO with PMNs,
AMs, IL-6, MMP9 and ET-1 concentrations in BALf. In this context, it is worth to note that lung HO-1
and iNOS were positively associated to the above mentioned pro-inflammatory BALf parameters
(Figure 7C). This evidence indicated a strong association between anti/pro-oxidant proteins roduction
and acute inflammation, o ce more confirmed by the correlatio between MPO concentration in BALf
and expression of inflammatory (MPO, COX-2) and oxidative stress (Cyp1b1, Hsp70) markers in heart,
as well to HO-1 in the lu g (Figure 7D).
Interestingly, after sub-acute treatment we observed a correlation among all the markers analyzed
in heart parenchyma (Figure 8A). In parallel, COX-2 protein levels in lung correlates with the phagocytic
cells influx in BALf and to Cyp1b1 and Hsp70 in heart (Figure 8B). This evidence reinforcing the
hypothesis that under repeated exposures to UFPs, pro-inflammatory and oxidative molecules produced
by initial deposition in the lung, reach further organs through circulation. All correlations analyses are
reported in Table S2.
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3. Materials and Methods
3.1. UFPs Characterization
DEP and BB batches were provided by ENEA (Agenzia Nazionale per Le Nuove Tecnologie,
L’Energia e Lo Sviluppo Economico Sostenibile) in the framework of the project “Biological effects and
human health impacts of ultrafine particles sources” lead by Prof Camatini of the POLARIS research
centre. Particle sampling procedures and their characterization are extensively reported elsewhere [56].
Briefly, DEP were sampled from five Teflon filters (Whatman pure Teflon filters, Maidstone, United
Kingdom) obtained by a diesel Euro 4 light- uty vehicle without an anti-particulate filter fuelled by
commercial diesel and run over a chassis dyno, while BB particles were collected from five Teflon filters
(Whatman pure Teflon filters) obtained by a modern automatic 25 kW boiler propelled by a prime
quality spruce pellet. Tra smission electro microscopy (TEM) and scanning electro microscopy
(SEM) images of both diesel and biomass samples showed aggregates of round carbonaceous particles
lower than 50 nm; in addition, biomass samples showed the presence of ash particles that completely
dissolve in aqueous media [56]. PAHs and transition metals (Fe, Zn, Cr, Pb, V and Ni) concentration
was higher in DEP compared to BB, which conversely resulted enriched i elements typical of wood
combustion, such as Mn, K and S. Below we provide a table (Table 2) summarizing the results obtained
by Longhin and colleagues [56].
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Table 2. Chemical compositions of UFPs from different anthropogenic sources, reported in Longhin et
al., 2016. [56] Each value is expressed as mean concentrations (±SD).
Elements Unit DEP BB
Al ng/µg 135 ± 4 ND
K ng/µg 50 ± 0.02 195 ± 12.5
Ca ng/µg 198 ± 8 70 ± 4
Fe ng/µg 4 ± 0.001 ND
Zn ng/µg 70 ± 2 4 ± 0.001
Cr ng/µg 0.04 ± 0.001 ND
Mn ng/µg 0.03 ± 0.001 0.42 ± 0.03
V ng/µg 0.05 ± 0.007 ND
Ni ng/µg 0.02 ± 0.001 ND
Pb ng/µg 0.02 ± 0.001 ND
Total PAHs ng/mg 600 ± 150 50 ± 10
3.2. Animals and Treatments
3.2.1. Animal Housing
Male BALB/cOlaHsd mice (7–8 weeks old, 20–25 g weight) were purchased from Envigo (San Pietro
al Natisone, Italy) with a health monitoring report based on FELASA recommendations. Mice were
housed in plastic cages in groups of three for five days to acclimate to the housing facility. They were
housed under controlled environmental conditions (temperature 19–21 ◦C, humidity 40–70%, lights on
7 a.m.–7 p.m.) with food and water administered ad libitum. Animal use and care procedures were
approved by the Institutional Animal Care and Use Committee of the University of Milano-Bicocca
(protocol 02-2014) and complied with guidelines set by the Italian Ministry of Health (DL 26/2014
“Application of the Directive n. 2010/63/EU on the protection of animals used for scientific purposes”).
3.2.2. Intratracheal Instillation
Animal testing has been carried out in the morning in the housing facility. Animals were randomly
divided into three experimental groups (three mice for each group) for exposition to the different UFPs
both in acute and sub-acute treatment: sham (isotonic solution); BB-treated mice and DEP-treated mice.
The experiments were replicated twice, for a total of 6 shams, 6 BB- and 6 DEP-treated mice for each
type of treatment. The sample size is in line with previously published data on air pollutant adverse
effects [30,32] with the aim to minimize the number of animals employed. Every mouse, numbered
from 1 to 9 (1–3 CTRL; 4–6 DEP; 7–9 BB), was singularly exposed to a mixture of 2.5% isoflurane
(flurane) anesthetic gas and kept under anesthesia during the whole instillation procedure. Once a
deep stage of anesthesia was reached, mice were intratracheally instilled by means of a MicroSprayer
Aerosolizer system (MicroSprayer Aerosolizer- Model IA-1C and FMJ-250 High-Pressure Syringe,
Penn Century, Philadelphia, PA, USA), with 100 µL of isotonic saline solution (sham) or 50 µg of
BB or DEP in 100 µL of isotonic saline solution (exposed). The entire procedure of intratracheal
instillation is fully described in previous works [62,73]. UFP dosage was chosen considering previous
in-vivo investigation [74–76] that suggested 50 µg/mice dose as the most appropriate one for detection
of acute and sub-acute inflammatory changes in lung exposition. Although, UFPs is at ambient
background levels < 2 µg/m3, it can increase severalfold at locations with high volumes of traffic
or during high-pollution episodes [77]. UFP dose here used is the lowest dose to establish lung
inflammatory response in exposed mice.
According to our published data with PM [62], 3 h after instillation is the proper time point to
evaluate some protective or inflammatory markers most likely expressed in acute phase (Figure 9A).
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Instead, mice subjected to three repeated instillations of 50 µg UFPs/instillation every three days
are consider representative of a sub-acute exposure (Figure 9B) [30–32,78]. Three h after a single
instillation or 24 h after the last instillation of the repeated exposure protocol, mice of each experimental
group (sham, BB and DEP-treated) were anesthetised by gas to minimize suffering and euthanized
with cervical dislocation. The Broncho Alveolar Lavage Fluid (BALf), lung, heart of every mouse have
been collected as described previously [30,32] and analyzed for markers of cytotoxicity, inflammation
and oxidative stress.
3.3. Bronchoalveolar Lavage Fluid Analysis
The BALf procedure, pellets, and supernatant recovery were performed as described
previously [62,73]. Briefly, the trachea was exposed, cannulated and secured with suture thread,
and three in-and-out washes with 0.6 mL of isotonic saline solution were performed [47]. The efficacy
of BALf collection ranged from 50% to 90% of the total solution injected. The BALf was centrifuged at
1500× g for 15 min at 4 ◦C [79] and pellets collected for cell counts. Supernatants were divided into
aliquots and appropriately stored for subsequent biochemical analyses.
3.3.1. Cell Counts
Total and differential cell counts have been performed according to the literature [62,73].
Briefly, BALf pell ts were resuspended in 500 µL of DMEM (10% FBS, 1% p nicillin-streptomycin,
1% glutamine), and total cell counts performed with a Burker chamber, using the Trypan Blue exclusion
me hod. A cell aliquot (240,000 cells, 800 cells/µL) was smeared in dupl cate onto slides using StatSpi
Cy ofuge 2 (Beckman Coulter Brea, CA, USA) 40× g for 7 min at room mperature. Subsequently,
the smears were stained with Diff Quik (Medion Dia nostic, Miami, FL, USA) for cell differential count,
according to th m nufacturer’s instr ctions. Macrophages, polymorphonuclear leukocytes (PMNs)
and lymphocytes were identified by their characteristic shapes.
3.3.2. Biochemical Analyses on cell-free BALf Supernatants
Pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6),
as well as the metalloproteinase MMP9, were a alyzed by me ns of Luminex Screening Assay by
LABOSPACE (Milano, Italy). The commercially available kits for alkaline phosphatas (ALP) activity
(DALP-250 QuantiChrom Alkaline Phosph tase Ass y Kit, Gent ur Molecular, (San Jose, CA, USA),
lactate dehydrogenase (LDH) ctivity (DLDH-100 QuantiChrom Lactate Dehydrogenase Kit, Gentaur
Molecular) were employed according to the manufacturers’ instructions.
Endoth lin-1 (ET-1) and heat shock protein 70 (Hsp70) conc ntration were assayed by means of
commercially available ELISA kits (Endothelin-1 ELISA kit and HSP70 high sensitivity ELISA kit, Enzo
Life Sciences, (Rome, Italy), according to manufacturer’s instructions.
Total Antioxidant Cap city (TAC) was ev luated by means of TAC Colorimetric Assay Kit
(BioVision, Milpitas, CA, USA) according to manufacturer’s instructions, in order to analyse the overall
cell capability to counteract reactive oxygen species (ROS). Briefly, Cu2+ ion i convert d t reduced Cu+
ion by both antioxidant small molecule and protein. Th r duced Cu+ is chelated with a colorimetric
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probe giving a broad absorbance peak around 570 nm, proportional to the total antioxidant capacity.
All measurements performed were normalized to the total protein content evaluated by means of the
bicinchoninic acid assay (BCA). Myeloperoxidase (MPO) analysis was performed by western blotting,
as described in Section 3.6.
3.4. Lung and Heart Homogenization
Lung and heart homogenates of sham, BB- and DEP-treated mice have been prepared and proteins
were processed as previously described [30]. Briefly, the lungs and the heart of sham and treated mice,
at the end of BAL procedure, were quickly excised from the chest and washed in ice-cold isotonic saline
solution. The left lobes were dissected and submitted to histology, the right lobes were preserved
for the western blot analyses. For protein assays, lungs were minced at 4 ◦C, suspended in NaCl
0.9%, briefly homogenized for 30 s at 11,000 rpm with Ultra-Turrax T25 basic (IKA WERKE, Staufen,
Germany) and sonicated for other 30 s. Protein amount was determined by BCA method (Sigma
Aldrich, St Louis, MO, USA).
3.5. Histopathological Analysis
Once excised, lungs and hearts from sham BB- and DEP-treated mice were washed with 0.1 M
phosphate buffered saline (PBS, pH 7.4), fixed by immersion in 10% buffered formalin o/n at RT,
embedded in paraffin (Embedding Center Leica EG1160, Leica Biosystem, Wetzlar, Germany),
cross-sectioned at 3 µm thickness by a rotary microtome, mounted on slides, and stained by
Haematoxylin and Eosin (HE). Finally, they were observed under a light microscope (Nikon Eclipse
50i, Melville, NY, USA). Representative images were captured with a digital camera (Nikon Digital
Sight DS-2Mv). Data were obtained from two sham, two BB- treated and two DEP-treated mice.
3.6. Electrophoresis and Immunoblotting
Protein analysis was performed by SDS-PAGE electrophoresis/western blot, loading 30 µg each
sample. Proteins were transferred to a nitrocellulose membrane (Amersham, GE Healthcare Europe
GmbH, Milano, Italy), and revealed by immunoblotting with specific antibodies: rabbit polyclonal
heme oxygenase-1 (HO-1) (1:200)(sc-10789; Santa Cruz Biotechnology™, Dallas, TX, USA), rabbit
polyclonal inducible nitric oxide synthase (iNOS) (1:200) (sc-8310; Santa Cruz Biotechnology™),
rabbit polyclonal cytochrome 1b1 (Cyp1b1) (1:200) (sc-32882; Santa Cruz Biotechnology™), goat
polyclonal heat shock protein 70 (Hsp70) (1:200)(sc-10-70; Santa Cruz Biotechnology™), rabbit
polyclonal cyclooxygenase 2 (COX2) (1:1000)(#4842; Cell Signalling Technology®, Danvers, MA,
USA), and rabbit polyclonal myeloperoxidase (MPO) (1:200) (sc-16128-R; Santa Cruz Biotechnology™).
The secondary antibodies were appropriate horseradish peroxidase (HRP)-conjugated goat anti-rabbit
(1:5000) (31460 Thermofisher Scientific™ Waltham, MA, USA) or donkey anti-goat (1:2000) (sc-2020;
Santa Cruz Biotechnology™). Immunoblot bands have been analyzed and the optical density quantified
by LAS4000 (GE Healthcare, Marlborough, MA, USA); all the data have been normalized to Ponceau
staining (Sigma Chemical Co., Milano, Italy) [78].
3.7. Fluorescence Molecular Tomography
Fluorescence molecular tomography (FMT®) is an imaging technique for improved fluorescence
signals localization and quantification in deep tissue. After hair removal, male BALB/c mice were
injected intravenously with MMPSenseTM 750 FAST probe, immediately before the first and the last
instillation of the sub-acute treatment. MMPSenseTM 750 FAST probe is a matrix metalloproteinase
(MMP) activatable agent that is optically silent upon injection but after cleavage by MMPs becomes
fluorescent. The recommended optimal imaging time point is 6–24 h post-injection of the probe,
to allow its distribution and the decrease of background signal; thus the evaluation after 3 h from
single instillation was not possible. For this reason in-vivo imaging was performed during sub-acute
treatment after 24 h from the first (day 1) and the last (day 6) instillation, in order to compare the effects
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of the single and the repeated exposures., Analyses was performed using the FMT 1500TM In Vivo
Imaging System (PerkinElmer, Waltham, MA, USA).
The total amount of fluorophore in a selected three-dimensional region of interest (ROI) was
calculated by the TrueQuant software. ROI was drawn with the same size each sample and so as
to include the whole cardiopulmonary area. ROIs drawing was executed in a blind manner by an
operator unaware of the experimental origin of the specimens in order to eliminate any operator bias.
3.8. Statistical Analysis
Data were assembled with Galaxy (doi:10.1093/nar/gky379) [80] and analyzed with the IBM SPSS
Statistical Package v25 (IBM, Armonk, NY, USA). Linear regression analyses were performed by
Pearson correlation. Differences between groups (i.e., sham, DEP- and BB-treated mice) were calculated
by ANOVA with Bonferroni multiple-comparison post-hoc correction. A significance threshold of
p ≤ 0.05 was used.
4. Conclusions
In summary, DEP exposure was more harmful than BB. Indeed, although both of them induce
inflammatory pathways, only DEP leads to strong oxidative stress activation in lung and heart
parenchyma. Data obtained indicated that the chemical composition of UFPs is the key to the
differential stress response. In fact, the main contribution in oxidative stress induction after DEP
instillation is associated to higher concentrations of PAHs on diesel exhausted particles as compared to
BB. On the contrary, the necrotic damage caused by both kind of particles could be specifically related
to their physical nature.
Here we showed that acute instillation elicited a stress response in both lung and heart
characterizing a systemic damaging status. After repeated UFPs treatments, instead, BALf and
lung parenchyma analysis did not disclose the presence of ongoing oxidative stress but at least a
moderate cell-mediated immunity and inflammatory status. Therefore, we could hypothesize that lungs
established some compensatory mechanisms in order to limit the toxic reaction and that the protective
proteins, generated after a single treatment, achieved their function. Nevertheless, the inflammatory
and oxidative stress pathways were activated in the cardiac tissue after repeated instillation.
Since heart histologic analysis did not show any evident deposition of UFPs, that were instead
persistent in the lung, alterations in heart parenchyma could be probably due to the translocation of
harmful mediators produced in the lung. Therefore, a multiorgan analysis should be interesting to
investigate the hypothesis of systemic damaging effects of UFP exposure.
Our compelling evidence adds to a growing literature on the association between UFP exposure
and adverse health outcomes. It is in line with studies performed on human subjects that highlighted
the association of traffic-related air pollution with an acute decrement of lung function, elevated
systemic inflammation [81], and the activation of several inflammatory and redox pathways (i.e.,
leukotriene and inflammatory mediators, cytochrome P450 etc) [82]. Furthermore, the beneficial
effects of outdoor physical activity are reduced in high density traffic areas, particularly in the case of
patients with chronic cardiopulmonary disease [83]. Thus, major local and international efforts need to
be putted in air pollution exposure reduction, to counteract an increasingly worldwide problem for
the health.
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